http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015157653-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a08943cf95b7bf75fff3c69d5c3df82b |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
filingDate | 2013-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adaaaf45f5d9a5643c06bdb625633ce6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b0a636a35e232d6b82fad4f34d7d71d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_564877bb81fdfe70c923ccf112c96d40 |
publicationDate | 2015-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2015157653-A1 |
titleOfInvention | Prevention of Clostridium Difficile Infection in High Risk Patients |
abstract | The present invention relates to methods of preventing Clostridium difficile infection (COI) in a human subject who is at high risk of developing this infection, comprising administering to the subject an effective amount of the compounds described herein. In some embodiments, the subject is further receiving concomitant antibiotic therapy to prevent and/or treat an infection other than Clostridium . In some embodiments, the subject previously was treated for a Clostridium infection. In some embodiments, the compound of formula I prevents the Clostridium infection. |
priorityDate | 2012-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 166.